Results 261 to 270 of about 682,662 (388)
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski +15 more
wiley +1 more source
Electronic health records in ambulatory care--a national survey of physicians.
C. DesRoches +10 more
semanticscholar +1 more source
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi +11 more
wiley +1 more source
Hip resection arthroplasty as a primary treatment of displaced neck fracture in non-ambulatory and fragile patients. [PDF]
Regis D +5 more
europepmc +1 more source
Finerenone in patients with severe heart failure: The FINEARTS‐HF trial
Severe heart failure and treatment with finerenone. CI, confidence interval; CV, cardiovascular; HF, heart failure; LVEF, left ventricular ejection fraction; RR, rate ratio. Aims While patients with severe heart failure (HF) were historically considered to have reduced left ventricular ejection fraction (LVEF), it is increasingly recognized that severe
Riccardo M. Inciardi +24 more
wiley +1 more source
Associations Between Online Search Trends and Outpatient Visits for Common Medical Symptoms in the United States from 2004 to 2019: Time Series Ecological Study. [PDF]
Heumann R, Steinhubl SR.
europepmc +1 more source
Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT.
Gianluigi Savarese +37 more
wiley +1 more source

